NO943654L - Decorin fragments and methods for inhibiting cell regulatory factors - Google Patents
Decorin fragments and methods for inhibiting cell regulatory factorsInfo
- Publication number
- NO943654L NO943654L NO943654A NO943654A NO943654L NO 943654 L NO943654 L NO 943654L NO 943654 A NO943654 A NO 943654A NO 943654 A NO943654 A NO 943654A NO 943654 L NO943654 L NO 943654L
- Authority
- NO
- Norway
- Prior art keywords
- cell regulatory
- methods
- protein
- regulatory factors
- cell
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/71—Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4725—Proteoglycans, e.g. aggreccan
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/20—Fusion polypeptide containing a tag with affinity for a non-protein ligand
- C07K2319/24—Fusion polypeptide containing a tag with affinity for a non-protein ligand containing a MBP (maltose binding protein)-tag
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/50—Fusion polypeptide containing protease site
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
- C07K2319/73—Fusion polypeptide containing domain for protein-protein interaction containing coiled-coiled motif (leucine zippers)
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Toxicology (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Cell Biology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
Abstract
Fremgangsmåte for inhibering av en aktivitet av en celleregulerings- faktor som omfatter å bringe celle- reguleringsfaktoren i kontakt med et renset polypeptid, hvor polypeptidet omfatter et cellereguleringsfaktorbin- dende domene fra et protein. Proteinet karakteriseres ved en leucinrik repeti- sjon på tilnærmet 24 aminosyrer. I en spesifikk utførelse gjelder foreligg- ende oppfinnelse evnen til decorin, et protein på 40.000 dalton som vanligvis bærer en glykosaminoglykankjede, og mer spesifikt aktive deoorinfragmenter eller disses funksjonelle ekvivalenter, til å binde TGFp. Oppfinnelsen tilveie- bringer også en ny cellereguleringsfak- tor kalt MRF. Videre tilveiebringes fremgangsmåter for identifisering, på- visning og rensing av celleregulerings- faktorer og proteiner som binder og påvirker aktiviteten av cellereguler- ings faktorer.A method of inhibiting an activity of a cell regulatory factor comprising contacting the cell regulatory factor with a purified polypeptide, wherein the polypeptide comprises a cell regulatory factor binding domain of a protein. The protein is characterized by a leucine-rich repetition of approximately 24 amino acids. In a specific embodiment, the present invention relates to the ability of decorin, a 40,000 dalton protein that usually carries a glycosaminoglycan chain, and more specifically active deoorin fragments or their functional equivalents, to bind TGFβ. The invention also provides a new cell regulation factor called MRF. Furthermore, methods are provided for identifying, detecting and purifying cell regulatory factors and proteins that bind and affect the activity of cell regulatory factors.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US86565292A | 1992-04-03 | 1992-04-03 | |
PCT/US1993/003171 WO1993020202A1 (en) | 1992-04-03 | 1993-04-02 | Decorin fragments and methods of inhibiting cell regulatory factors |
Publications (2)
Publication Number | Publication Date |
---|---|
NO943654D0 NO943654D0 (en) | 1994-09-30 |
NO943654L true NO943654L (en) | 1994-12-05 |
Family
ID=25345963
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO943654A NO943654L (en) | 1992-04-03 | 1994-09-30 | Decorin fragments and methods for inhibiting cell regulatory factors |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP0636175A1 (en) |
JP (1) | JPH07508403A (en) |
AU (1) | AU679178B2 (en) |
CA (1) | CA2132859A1 (en) |
FI (1) | FI944575A (en) |
NO (1) | NO943654L (en) |
WO (1) | WO1993020202A1 (en) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE69418322D1 (en) * | 1993-03-01 | 1999-06-10 | Glycan Pharm Inc | ANALOGS FOR SPECIFIC OLIGOSACCHARID-PROTEIN INTERACTIONS AND THEIR USE |
US5567807A (en) * | 1994-07-08 | 1996-10-22 | La Jolla Cancer Research Foundation | Processes for the purification of human recombinant decorin and the detection of guanidinium ions |
WO2005116066A1 (en) * | 2004-05-31 | 2005-12-08 | National University Of Singapore | Peptides derived from decorin leucine rich repeats and uses thereof |
EP1806359B1 (en) * | 2005-09-05 | 2010-03-17 | Immatics Biotechnologies GmbH | Tumor-associated peptides binding promiscuously to human leukocyte antigen (HLA) class II molecules |
ES2283212B1 (en) * | 2006-03-31 | 2008-08-16 | Lipotec S.A. | USEFUL SYNTHETIC PEPTIDES IN THE TREATMENT OF SKIN AND ITS USE IN COSMETIC OR DERMOPHARMACEUTICAL COMPOSITIONS. |
HU0700024D0 (en) * | 2007-01-11 | 2007-03-28 | Mta Szegedi Biolog Koezpont | Use of enhancers in biglycan activuty in the preparation of pharmaceutical compositions having utility in cardiac diseases |
EP2538221A3 (en) * | 2007-11-05 | 2013-04-24 | Nordic Bioscience A/S | Biochemical markers for CVD risk assessment |
WO2012125626A2 (en) * | 2011-03-14 | 2012-09-20 | Catalent Pharma Solutions Llc | Decorin compositions and use thereof |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1991010727A1 (en) * | 1990-01-22 | 1991-07-25 | La Jolla Cancer Research Foundation | Inhibitors of cell regulatory factors |
-
1993
- 1993-04-02 EP EP93909477A patent/EP0636175A1/en not_active Withdrawn
- 1993-04-02 JP JP5517752A patent/JPH07508403A/en active Pending
- 1993-04-02 WO PCT/US1993/003171 patent/WO1993020202A1/en not_active Application Discontinuation
- 1993-04-02 CA CA002132859A patent/CA2132859A1/en not_active Abandoned
- 1993-04-02 AU AU40257/93A patent/AU679178B2/en not_active Ceased
-
1994
- 1994-09-30 NO NO943654A patent/NO943654L/en unknown
- 1994-09-30 FI FI944575A patent/FI944575A/en unknown
Also Published As
Publication number | Publication date |
---|---|
AU679178B2 (en) | 1997-06-26 |
EP0636175A1 (en) | 1995-02-01 |
CA2132859A1 (en) | 1993-10-14 |
JPH07508403A (en) | 1995-09-21 |
NO943654D0 (en) | 1994-09-30 |
FI944575A0 (en) | 1994-09-30 |
FI944575A (en) | 1994-11-29 |
WO1993020202A1 (en) | 1993-10-14 |
AU4025793A (en) | 1993-11-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO941821D0 (en) | Inhibitors of cell regulation factors as well as methods of prevention or reduction of scarring | |
NZ501767A (en) | Cyclic integrin binding peptide with the amino acid sequence RKK | |
Jander et al. | A collagen-like glycoprotein of the extracellular matrix is the undegraded form of type VI collagen | |
ATE224713T1 (en) | USE OF PYRIDYL-ALKANEOUS, PYRIDIYL ALKANEOUS AND/OR PYRIDYL ACIDS AMIDES FOR THE TREATMENT OF TUMORS OR FOR IMMUNOSUPRESSION | |
Lewis et al. | The amino acid sequence of rabbit cardiac tropomyosin. | |
KR970702917A (en) | Soluble polypeptide fragment of LAG-3 and production method, therapeutic composition, anti-idiotype antibody | |
IL101728A0 (en) | Human notch and delta,binding domains in toporhythmic proteins,and methods based thereon | |
NO943654L (en) | Decorin fragments and methods for inhibiting cell regulatory factors | |
NO179412C (en) | Hybrid DNA molecule encoding fibronectin-binding protein, microorganisms containing such DNA molecules, and method of producing such protein | |
NZ236094A (en) | Recombinant protein complex having human factor viii:c activity | |
Gellerfors et al. | Analysis of the Peptide Composition of Purified Beef‐Heart Complex III by Dodecylsulfate Electrophoresis | |
DK0572688T3 (en) | Peptides, with organ-protective activity, method for their preparation and their use in therapy | |
DE69435020D1 (en) | Protein-tyrosin-phosphatase ptp-s31 | |
KR960006937A (en) | Human interleukin-6 inhibitor | |
NO962084L (en) | DNA sequence encoding a BMP receptor | |
HK1043372A1 (en) | Hypoxia-inducible factor 1a hif-1a variants and methods for identifying hif-1a modulators | |
EP0319315A3 (en) | The von willebrand factor binding domain of factor viii | |
Madsen et al. | Analysis of collagen types synthesized by rabbit ear cartilage chondrocytes in vivo and in vitro | |
ATE291088T1 (en) | IMMUNOLOGICALLY ACTIVE PROTEINS OF BORRELIA BURGDORFERI, NUCLEIC ACIDS CODING THEREOF AND THEIR USE IN TEST KITS AND AS VACCINES | |
NO922421L (en) | COLLAGEN-BINDING PROTEIN, AND PREPARATION OF THEREOF | |
DE69837265D1 (en) | POLYPEPTIDES FOR REGENERATING THE NERVOUS SYSTEM | |
Lester et al. | Human alpha-fetoprotein: immunosuppressive activity and microheterogeneity | |
Ayad et al. | Type VI collagen and glycoprotein MFPI are distinct components of the extracellular matrix. | |
ATE180679T1 (en) | NEW IMPROVEMENTS TO RADIOM LABELING OF PROTEINS | |
WO1997014966B1 (en) | Method of activating a novel ligand regulatory pathway |